Colloidal drug aggregates prolong effect of glaucoma medicine up to seven weeks with a single, non-invasive injection ...

Susvimo 100 mg/mL for intravitreal use via ocular implant is a refillable implant surgically inserted into the eye during a ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...

Roche’s Susvimo, a refillable eye implant for diabetic macular edema, provides continuous delivery of ranibizumab, showing ...

Medication is sometimes necessary to treat eye conditions and vision problems. Of course, this is highly dependent on the ...

The new indication adds to the 2021 approval of Susvimo (ranibizumab) for 'wet' or neovascular age-related macular ...

At a single academic tertiary referral center, mild intraocular inflammation developed in four eyes following intravitreal ...

The results of this study show that the COVID-19 pandemic caused a notable drop in the number of common ophthalmic procedures among Medicare beneficiaries, especially in laser peripheral iridotomy, ...

The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.

The number of common ophthalmic procedures among Medicare beneficiaries overall declined by 17.9% during the COVID-19 pandemic, according to a report published Thursday in JAMA Ophthalmology.

Q. Every so often, my left eye twitches. It goes away after a while, but it’s annoying. Is there a remedy? A. Eye-twitching – also called eye spasms or blinking disorder – is ...